TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive NCI, DOE Working Out Details Of Converting Portion Of Idaho Facility to Work On BNCT July 1, 1988